4.3 Review

Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage in vivo

期刊

ONCOTARGET
卷 8, 期 34, 页码 57605-57621

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.17745

关键词

arsenic; reactive oxygen species (ROS); genomic instability; antioxidants; cancer prevention

资金

  1. US National Institutes of Health [NCI R01CA094962, NCI R01CA213987]
  2. Stephenson Cancer Center

向作者/读者索取更多资源

Through contaminated diet, water, and other forms of environmental exposure, arsenic affects human health. There are many U.S. and worldwide hot spots where the arsenic level in public water exceeds the maximum exposure limit. The biological effects of chronic arsenic exposure include generation of reactive oxygen species (ROS), leading to oxidative stress and DNA damage, epigenetic DNA modification, induction of genomic instability, and inflammation and immunomodulation, all of which can initiate carcinogenesis. High arsenic exposure is epidemiologically associated with skin, lung, bladder, liver, kidney and pancreatic cancer, and cardiovascular, neuronal, and other diseases. This review briefly summarizes the biological effects of arsenic exposure and epidemiological cancer studies worldwide, and provides an overview for emerging rodent-based studies of reagents that can ameliorate the effects of arsenic exposure in vivo. These reagents may be translated to human populations for disease prevention. We propose the importance of developing a biomarker-based precision prevention approach for the health issues associated with arsenic exposure that affects millions of people worldwide.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice

Hiroshi Y. Yamada, Yuting Zhang, Arun Reddy, Altaf Mohammed, Stan Lightfoot, Wei Dai, Chinthalapally V. Rao

CARCINOGENESIS (2015)

Article Biochemistry & Molecular Biology

Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability model

Chinthalapally V. Rao, Saira Sanghera, Yuting Zhang, Laura Biddick, Arun Reddy, Stan Lightfoot, Wei Dai, Hiroshi Y. Yamada

MOLECULAR CARCINOGENESIS (2016)

Article Oncology

Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice

Chinthalapally V. Rao, Saira Sanghera, Yuting Zhang, Laura Biddick, Arun Reddy, Stan Lightfoot, Naveena B. Janakiram, Altaf Mohammed, Wei Dai, Hiroshi Y. Yamada

CANCER RESEARCH (2016)

Review Oncology

Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer

Chinthalapally V. Rao, Adam S. Asch, Hiroshi Y. Yamada

CARCINOGENESIS (2017)

Article Biochemistry & Molecular Biology

Emerging links among Chromosome Instability (CIN), cancer, and aging

Chinthalapally V. Rao, Adam S. Asch, Hiroshi Y. Yamada

MOLECULAR CARCINOGENESIS (2017)

Article Cell Biology

Spontaneous development of Alzheimer's disease-associated brain pathology in a Shugoshin-1 mouse cohesinopathy model

Chinthalapally V. Rao, Mudassir Farooqui, Yuting Zhang, Adam S. Asch, Hiroshi Y. Yamada

AGING CELL (2018)

Article Cell Biology

Critical role of mitosis in spontaneous late-onset Alzheimer's disease; from a Shugoshin 1 cohesinopathy mouse model

Chinthalapally V. Rao, Mudassir Farooqui, Adam S. Asch, Hiroshi Y. Yamada

CELL CYCLE (2018)

Review Cell Biology

Amyloid-beta accumulation cycle as a prevention and/or therapy target for Alzheimer's disease

Chinthalapally V. Rao, Adam S. Asch, Daniel J. J. Carr, Hiroshi Y. Yamada

AGING CELL (2020)

Article Cell Biology

GSK3-ARC/Arg3.1 and GSK3-Wnt signaling axes trigger amyloid-β accumulation and neuroinflammation in middle-aged Shugoshin 1 mice

Chinthalapally Rao, Mudassir Farooqui, Avanish Madhavaram, Yuting Zhang, Adam S. Asch, Hiroshi Y. Yamada

AGING CELL (2020)

Article Oncology

Survival-Critical Genes Associated with Copy Number Alterations in Lung Adenocarcinoma

Chinthalapally V. Rao, Chao Xu, Mudassir Farooqui, Yuting Zhang, Adam S. Asch, Hiroshi Y. Yamada

Summary: Genomic instability plays a crucial role in the evolution and treatment of lung adenocarcinoma, with genes associated with survival potentially serving as future therapeutic targets. The immune system has been identified as a key player in suppressing genomic instability and cancer development in the lungs, suggesting potential avenues for chemotherapy, chemoprevention, and immunomodulation approaches.

CANCERS (2021)

Article Multidisciplinary Sciences

Genomic instability genes in lung and colon adenocarcinoma indicate organ specificity of transcriptomic impact on Copy Number Alterations

Chinthalapally V. V. Rao, Chao Xu, Yuting Zhang, Adam S. S. Asch, Hiroshi Y. Y. Yamada

Summary: This study identified specific genes associated with genomic instability in colorectal cancer, providing new insights and targets for the development of therapeutic approaches.

SCIENTIFIC REPORTS (2022)

Article Oncology

Pancreatic Cancer Disparities among Gender, Race, and Ethnicity: The PRECEDE Consortium Outcomes and Impact

Hiroshi Y. Yamada, Chinthalapally V. Rao

Summary: The PRECEDE Consortium was launched internationally to evaluate the surveillance of high-risk individuals (HRI) of pancreatic cancer, focusing on genetic risk factors. During the early recruitment period from May 2020 to March 2022, data on 1,113 HRIs were collected. In this Cancer Prevention Research article, Katona and colleagues reported the demographics of the participants, revealing significant disparities in gender, race, and ethnicity. The PRECEDE Consortium now aims to address these disparities and increase the representation of underrepresented groups in the next 3 years.

CANCER PREVENTION RESEARCH (2023)

Article Oncology

Molecular disparities in colorectal cancers of White Americans, Alabama African Americans, and Oklahoma American Indians

Hiroshi Y. Yamada, Chao Xu, Kenneth L. Jones, Philip H. O'Neill, Madka Venkateshwar, Srikanth Chiliveru, Hyung-Gyoon Kim, Mark Doescher, Katherine T. Morris, Upender Manne, Chinthalapally V. V. Rao

Summary: The majority of cancer samples analyzed in the US are from white people, resulting in biases in racial and ethnic treatment outcomes. Colorectal cancer rates are higher among African Americans in Alabama and American Indians in Oklahoma. Differences in transcriptomic profiles between racial groups may contribute to these disparities. The expression levels of certain genes and pathways differ significantly in CRCs of African Americans and American Indians compared to white individuals. Targeting strategies designed for white CRC patients may be less effective for these racial groups. These findings highlight the need for optimized interventions to address racial disparities in CRC treatment.

NPJ PRECISION ONCOLOGY (2023)

暂无数据